Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01962740 · ClinicalTrials.gov registry record · NA

Serial Evaluation of Drug-Eluting Stents Using OCT (STRUT-OCT)

A NA study, sponsored by North Texas Veterans Healthcare System.

Terminated
Registry status
NA
Development phase
3
Enrollment target

NCT01962740: Clinical Trial NA study, sponsored by North Texas Veterans Healthcare System.

NCT01962740 is a NA study that was terminated before completion, run by North Texas Veterans Healthcare System. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01962740, a NA study, was terminated before completion, sponsored by North Texas Veterans Healthcare System.

TERMINATED
Registry status
NA
Development phase
3 participants
Enrollment target

Study Summary

The study is proposed as a 48-patient randomized-controlled pilot study that will use Optical Coherence Tomography (OCT) imaging to compare stent strut coverage and malapposition of three second-generation Drug Eluting Stents (DES) \[Xience EES (Abbott Vascular, Santa Clara, CA), Resolute Integrity ZES (Medtronic, Minneapolis, MN) and Promus Element EES (Boston Scientific, Natick, MA)\] at 6 weeks post implantation. Study Hypothesis is that the rates of stent strut coverage and malapposition of the Xience EES, Promus EES and will be similar to each other and improved (higher rates of stent strut coverage and lower rates of malapposition) compared to the Resolute ZES at 6 weeks post-implantation.

Interventions

  • DEVICE Drug-eluting stent implantation

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2013-09
Est. Completion 2015-03
Phase NA

Why NCT01962740 stopped before completion

NCT01962740 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Drug-eluting stent implantation is the first listed.

NCT01962740 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01962740 about?

NCT01962740 is a clinical study titled "Serial Evaluation of Drug-Eluting Stents Using OCT (STRUT-OCT)". The study is proposed as a 48-patient randomized-controlled pilot study that will use Optical Coherence Tomography (OCT) imaging to compare stent strut coverage and malapposition of three second-generation Drug Eluting Stents (DES) \[Xience EES (Abbott Vascular, Santa Clara, CA), Resolute Integrity ...

What is the current status of trial NCT01962740?

This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2013-09. Estimated completion is 2015-03.

What interventions are being tested in trial NCT01962740?

The interventions under investigation include: Drug-eluting stent implantation (DEVICE).

Who is sponsoring clinical trial NCT01962740?

This trial is sponsored by North Texas Veterans Healthcare System, which has 23 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01962740's enrollment target sits among peer trials

3 1996th of 2000 higher than 4 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01962740, the US trial registry maintained by the National Library of Medicine. NCT01962740 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.